Validating Medical Supply Requirements for Emergent and Routine Care Aboard General Medical Officer (GMO) Platforms

摘要

To maintain force readiness, the Navy understands the need to keep pace with advances in medicine. This process should be conducted within an environment of focused medical logistics emphasizing responsiveness, flexibility, precision, and visibility. This can be accomplished by examining the clinical operations of shipboard medicine, identifying relationships between patient condition (PC) types, providers, clinical tasks, and medical supplies and then mapping the relationships to form a structure that describes the application of care aboard ship. The primary objective was the development of a medical supply knowledge base that includes details about the clinical relationships occurring in ships' medical departments. The purpose of the knowledge base was to extract the interactions between individual pieces of medical materiel and patient care to provide the Fleet visibility to track and monitor the effects of proposed changes in the Authorized Minimal Medical Allowance Lists (AMMALs). Two General Medical Officer (GMO) supply sets, the GMO sick-bay supplemental AMMAL 7016 and the GMO level-2 laboratory supplemental AMMAL 7019 were examined. Thirty-three clinicians developed GMO-level treatment profiles for 337 PCs known to occur aboard ship. Each profile was broken down into its individual treatment tasks. The medical gear to conduct the tasks was then identified and assigned. Once the supplies had been assigned to the tasks, they were separated into a revised GMO AMMAL 7016 and a revised GMO AMMAL 7019. The results showed that clinical care aboard OMO AMMAL platforms could be improved while using less materiel. Reductions were realized in weight, cube, and cost. Excluding the reductions in equipment, savings in consumable item costs totaled $471,667.12 across the Fleet. Because consumable supplies are routinely reordered, the savings would continue to accrue over time.